Christine Gustafson shares her story of living with Thyroid Eye Disease, where access to care and understanding often discriminates.

Viridian Therapeutics received breakthrough therapy designation from the FDA for veligrotug for the treatment of thyroid eye ...

Amgen (AMGN) stock in focus as its antibody drug Tepezza becomes U.K.'s first medicine for adults with moderate to severe ...

The current findings "show that age-, sex-, and race-based expected ranges for thyroid function tests should enhance our ...

It's the small organ with the big job. Found at the base of our necks, the thyroid gland helps almost every part of our ...

In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment.

There are a few eye conditions—from chronic and constant pain to blurred vision, redness, and seeing floaters, which are extremely common yet can be dangerous if not treated well in time. According to ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Thyroid Eye Disease Treatment ...

The European Medicines Agency (EMA) has recommended marketing authorization for Tepezza (teprotumumab) for adults with ...

EMA recommends marketing approval for Amgen Europe’s Tepezza to treat adults with moderate to severe thyroid eye disease: Amsterdam, The Netherlands Monday, April 28, 2025, 11:0 ...

Researchers reviewed the patient burden of mild-to-moderate thyroid eye disease treatments. Researchers must develop less burdensome therapies to improve the quality of life and reduce the amount of ...

Frimley Health NHS Foundation Trust is begin using a new drug to tackle thyroid eye disease A Surrey health trust says it is to become the first in the UK to trial a drug for a debilitating eye ...